These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4966135)

  • 1. [Results and indications of subcutaneous heparin in cardiovascular surgery].
    Courbier R; Monties JR; Baille Y; Henry E
    Arch Mal Coeur Vaiss; 1967 Nov; 60(11):1647-54. PubMed ID: 4966135
    [No Abstract]   [Full Text] [Related]  

  • 2. [Technical indications and results of subcutaneous heparin therapy during surgery of congenital cardiopathies in the child].
    Baille Y; Monties JR; Sommer A; Blanc T; Goudard A; Henry E
    Ann Pediatr (Paris); 1969; 16(6):464-7. PubMed ID: 5804371
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombosis and heart infarct prevention using subcutaneous heparin therapy].
    Steger W
    Fortschr Med; 1974 Jan; 92(2):76-9. PubMed ID: 4818252
    [No Abstract]   [Full Text] [Related]  

  • 4. [Low-dose subcutaneous heparin therapy in the prevention of thrombosis in hip fracture patients].
    Laky R
    Orv Hetil; 1974 Sep; 115(38):2223-7. PubMed ID: 4410042
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined treatment with aminocaproic acid and subcutaneous heparin in the prevention of thrombosis following prostatectomy.
    Borgström S; Becker J; Saltzman GF
    Zentralbl Phlebol; 1970 May; 9(2):105-11. PubMed ID: 5495121
    [No Abstract]   [Full Text] [Related]  

  • 6. [Subcutaneous heparin therapy].
    Mézac M; Marchand F; Pain C
    Soins; 1993 Nov; (578):61-2. PubMed ID: 8140476
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of subcutaneous heparin in children with severe infection. Prevention of coagulopathy or additional method of treatment?].
    Grygalewicz J; Niznikowska-Marks MJ; Kozierowska T; Rzacka D; Janus M
    Pediatr Pol; 1982 Dec; 57(12):1003-13. PubMed ID: 7182777
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prophylaxis and therapy of thrombotic diseases with subcutaneous heparin therapy].
    Tilsner V
    Med Welt; 1972 Oct; 23(43):1553-6. PubMed ID: 5086323
    [No Abstract]   [Full Text] [Related]  

  • 9. [Subcutaneous heparins].
    Thies HA; Gins R; Kuder E
    Med Welt; 1976 Nov; 27(46):2240-1. PubMed ID: 1004164
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prophylaxis of thrombosis with Calciparin].
    Erichsen J
    Med Welt; 1972 Sep; 23(39):1361-2. PubMed ID: 4639580
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacologic action of "low doses" or "small doses" of heparin administered subcutaneously].
    Raby C; Bertrand H
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2476. PubMed ID: 693287
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activation of the fibrinolytic system following subcutaneous administration and inhalation of heparin].
    Psuja P; Tokarz A; Turowiecka Z; Sowier J; Zawilska K
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):105-8. PubMed ID: 8361902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin necrosis related to subcutaneous heparin administration. Heparin necrosis].
    Berkessy S; Tuka P; Radványi G; Balyi G; Pauker Z; Somogyi E; Takács I
    Orv Hetil; 1981 Dec; 122(50):3075-80. PubMed ID: 7329684
    [No Abstract]   [Full Text] [Related]  

  • 14. [Various practical observations on the use of heparin in recent myocardial infarction].
    Mamont B
    Kardiol Pol; 1983; 26(1):85-8. PubMed ID: 6876537
    [No Abstract]   [Full Text] [Related]  

  • 15. [Continuous intra-arterial heparin therapy, a complement of reparative surgery. (Preliminary note)].
    Léna A; Mercier C; Baille Y; Imbert P
    Mem Acad Chir (Paris); 1966 Jun; 92(20):565-70. PubMed ID: 5947170
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subcutaneous heparin therapy in surgery].
    Courbier R; Monties JR; Baille Y; Henry E
    Mars Med; 1967; 104(2):157-63. PubMed ID: 5614701
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in general surgery].
    Schott G
    Z Gesamte Inn Med; 1984 Sep; 39(17):431-5. PubMed ID: 6506818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of injection duration on bruising associated with subcutaneous heparin: a quasi-experimental within-subject design.
    Balci Akpinar R; Celebioglu A
    Int J Nurs Stud; 2008 Jun; 45(6):812-7. PubMed ID: 17399715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
    Levy JH; Tanaka KA; Hursting MJ
    Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.